-
Good Supply Practice for Drugs
2022-06-30
Issued in Decree No. 20 of former CFDA on April 30, 2000, first revision in ministerial meeting of former Ministry of Health on November 6, 2012, second revision in the executive meeting of former CFDA on May 18, 2015, and amended according to the Decision to Amend the Good Supply Practice for Drugs of former CFDA on June 30, 2016
-
Announcement of the National Medical Products Administration, Ministry of Agriculture and Rural Affairs, National Forestry and Grassland Administration, and National Administration of Traditional Chinese Medicine on Issuing the Good Agricultural Practice for Chinese Crude Drugs
2022-03-17
The National Medical Products Administration, Ministry of Agriculture and Rural Affairs, National Forestry and Grassland Administration, and National Administration of Traditional Chinese Medicine formulated the Good Agricultural Practice, which was promulgated and implemented on March 1, 2022.
-
Announcement of NMPA and General Administration of Customs on the Establishment of Aidian Port as a Crude Drug Import Port
2022-03-16
According to the Drug Administration Law of the People's Republic of China, upon the approval of the State Council, it is agreed to establish Aidian Port, Chongzuo City, Guangxi Zhuang Autonomous Region (hereinafter referred to as Aidian Port) as a crude drug import port.
-
NMPA Announcement on Issuing the Provisions for the Administration of Adverse Reaction Monitoring of Cosmetics
2022-02-15
The NMPA formulated the Provisions for the Administration of Adverse Reaction Monitoring of Cosmetics, which was issued on February 15, 2022 and will come into force on October 1, 2022.
-
NMPA Announcement on the Good Manufacturing Practice for Cosmetics
2022-01-07
NMPA organized to formulate the Good Manufacturing Practice for Cosmetics (hereinafter referred to as the GMP), which was issued on January 6, and shall enter into force as of July 1, 2022.
-
NMPA Announcement on the Emergency Approval Procedure for Medical Devices
2021-12-29
National Medical Products Administration organized to revise the Emergency Approval Procedure for Medical Devices, which is issued and take effect as of December 29, 2021.